focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,757.00
Bid: 1,757.00
Ask: 1,758.00
Change: 1.00 (0.06%)
Spread: 1.00 (0.057%)
Open: 1,743.50
High: 1,759.00
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Astrazeneca leads FTSE higher on bid speculation

Thu, 21st Aug 2014 17:42

- Healthcare stocks lift FTSE- German PMI data drives sentiment- Investors look ahead to Draghi speech- UK retail sales disappointtechMARK 2,819.77 +0.82%FTSE 100 6,777.66 +0.33%FTSE 250 15,838.57 +0.57%London's blue chips ended Thursday's session on a positive note, led by Astrazeneca. Increased speculation regarding ECB action, on the heels of weaker than forecast readings on the Eurozone economy, were offset by a weak report on UK retail sales. After making gains both early and late on, the FTSE 100 ultimately closed 22 points higher at 6,778. July saw UK retail sales register their slowest annual gain since November, with volumes surprising with a slowdown to just a 0.1% rate of gain, compared to an advance of 0.2% in June. Expectations had been for a rise of 0.4%. Investors were also surprised to see that food sales declined, the first time on record that this has happened. The Office for National Statistics also released figures showing that while UK public finances improved last month borrowing still remained above the government's target.Across the Channel, Markit's 'flash' composite Purchasing Managers' Index (PMI), which tracks growth in the manufacturing and service sectors that make up more than two-thirds of the economy, fell to 54.9 in August from 55.7. However, it nonetheless remained well above the crucial 50 mark that separates growth from contraction.On the upside, Germany's private sector grew for a 16th month running in August, suggesting Europe's largest economy could expand robustly in the third quarter after it suffered a surprise contraction in the second.However, following those figures Barclays Research pointed out that it sees "material downside risks" to its forecast for the Eurozone's GDP to expand at 0.3% quarter-on-quarter clip in the third quarter. Meanwhile, the Jackson Hole Symposium of central bankers is due to kick off later Stateside with comments from policymakers around the world likely to be closely watched.Bid speculation sends Astrazeneca racing aheadHealthcare stocks gained strongly amid speculation Pfizer may make another bid for Astrazeneca. Smith & Nephew and GlaxoSmithKline also rose strongly. Financial stocks also made decent gains, with Hargreaves Lansdown, Standard Life, Old Mutual and Aviva all higher. Mining stocks led to the downside after metals consumer China disappointed with its manufacturing data and metals prices fell. Fresnillo, Randgold Resources, Anglo American, Rio Tinto and BHP Billiton all fell into the red. BHP was still under pressure in the aftermath of Tuesday's underwhelming plans for a demerger. Chief financial officer Graham Kerr, who is due to be the head of the spin-off company, has been cited as saying that the lack of a share buyback - which many investors had been expecting - was a "sore point", while plans to give shareholders stock in the new firm may have "irritated" some who are not mandated to hold investments in Australia. Oil stock Tullow Oil was also in the red. On the second tier, metal miner Kazakhmys hailed progress with a shake-up designed to focus it on the lucrative copper market, but said 2014 gold production was likely to fall short of hopes, pushing the stock into the red. Investec knocked Ophir Energy lower after it reduced its rating to 'hold' from 'buy' and lowered its target price to 250p from 315p.FTSE 100 - RisersAstraZeneca (AZN) 4,411.50p +2.95%Schroders (SDR) 2,392.00p +2.66%Hargreaves Lansdown (HL.) 1,133.00p +2.16%CRH (CRH) 1,401.00p +2.04%Barratt Developments (BDEV) 366.20p +1.84%Smith & Nephew (SN.) 1,064.00p +1.62%3i Group (III) 387.60p +1.57%Standard Life (SL.) 376.90p +1.48%Mondi (MNDI) 1,018.00p +1.39%Rolls-Royce Holdings (RR.) 1,037.00p +1.37%FTSE 100 - FallersFresnillo (FRES) 938.00p -3.55%Randgold Resources Ltd. (RRS) 4,904.00p -1.86%Kingfisher (KGF) 306.80p -1.67%Anglo American (AAL) 1,573.50p -1.29%Antofagasta (ANTO) 808.50p -1.28%Royal Mail (RMG) 440.30p -1.21%Petrofac Ltd. (PFC) 1,126.00p -1.14%easyJet (EZJ) 1,324.00p -1.12%Aberdeen Asset Management (ADN) 431.70p -1.10%Rio Tinto (RIO) 3,433.00p -0.72%FTSE 250 - RisersSenior (SNR) 292.40p +3.84%Hikma Pharmaceuticals (HIK) 1,742.00p +2.96%Ocado Group (OCDO) 377.90p +2.89%Phoenix Group Holdings (DI) (PHNX) 735.50p +2.87%RPS Group (RPS) 269.50p +2.86%Cranswick (CWK) 1,349.00p +2.82%International Personal Finance (IPF) 520.00p +2.77%Diploma (DPLM) 686.00p +2.62%Spirent Communications (SPT) 103.50p +2.48%Carillion (CLLN) 337.60p +2.30%FTSE 250 - FallersKazakhmys (KAZ) 291.10p -5.64%Petra Diamonds Ltd.(DI) (PDL) 183.60p -3.72%Ophir Energy (OPHR) 221.40p -3.61%Exova Group (EXO) 220.00p -3.51%Just Retirement Group (JRG) 146.20p -2.60%Thomas Cook Group (TCG) 121.00p -2.42%Electrocomponents (ECM) 239.80p -2.36%Ladbrokes (LAD) 132.30p -2.22%Lonmin (LMI) 212.90p -2.11%African Barrick Gold (ABG) 239.60p -1.80%AB
More News
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.